Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
Financials
Financial year 2025
SAINT-REMY BIOMEDICALS from Grez-Doiceau, company number BE0810927522, closed financial year 2025 with a result of € 9,473 after tax. For that financial year SAINT-REMY BIOMEDICALS recorded a gross margin of € 13,125 and equity of € -44,890. Compared with financial year 2024, the result moved from € 13,700 to € 9,473. The company is profitable. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on March 30, 2026.
€ -44,890
▲ € 9,473 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 9,473
▼ 31% vs 2024
Profit after tax over the fiscal year.
€ 36,954
▲ € 31,616 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -63,490.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 4,135
▲ € 3,664 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 3,057
▲ € 2,776 vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -4,040 | € 10,734 | € 14,566 | € 13,125 | ▼ 10% |
| Profit after taxes | € -4,664 | € 10,045 | € 13,700 | € 9,473 | ▼ 31% |
| Equity | € -78,107 | € -68,062 | € -54,362 | € -44,890 | ▲ € 9,473 |
| Total debts | € 99,485 | € 109,268 | € 103,219 | € 100,363 | ▼ 3% |
| Cash | € 2,859 | € 22,687 | € 5,338 | € 36,954 | ▲ € 31,616 |
| Retained profit | € -96,707 | € -86,662 | € -72,962 | € -63,490 | ▲ € 9,472 |
| Balance sheet total | € 21,378 | € 41,205 | € 48,857 | € 55,473 | ▲ 14% |
Key figures of SAINT-REMY BIOMEDICALS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
What happened to SAINT-REMY BIOMEDICALS?
What happened at SAINT-REMY BIOMEDICALS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 9,473 (▼ 31% vs 2024). Source: NBB ↗
- Start of the company according to the CBE. KBO
In short
From € 4,664 loss in 2022 to € 9,473 profit in 2025.
Paid € 3,615 in corporate taxes since 2022.
Best year ever: 2024, with € 13,700 profit.
A new publication or filing at SAINT-REMY BIOMEDICALS? We notify you, reason included.
Follow SAINT-REMY BIOMEDICALSDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind SAINT-REMY BIOMEDICALS is Jean-Marie SAINT-REMY. Jean-Marie SAINT-REMY is also behind THALIA.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Rue du Lambais 79
1390 Grez-Doiceau
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0810.927.522
- VAT number
- BE 0810.927.522
- Registered office
- Rue du Lambais 79, 1390 Grez-Doiceau
- Names & denominations
- SAINT-REMY BIOMEDICALS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 9 March 2009
- Peppol
- Active · Active since 24 Nov 2023
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Activiteiten van medische beeldvorming en medische laboratoria
Activiteiten van medische laboratoria
Overige gespecialiseerde wetenschappelijke en technische activiteiten